Anticancer Drugs
Total Page:16
File Type:pdf, Size:1020Kb
THE BAYER SCHOOL OF NATURAL AND ENVIRONMENTAL SCIENCES Distinguished Scientists Lecture Series UNDERSTANDING AND IMPROVING PLATINUM ANTICANCER DRUGS THURSDAY, DEC. 4, 7 P.M. Pappert Lecture Hall | Duquesne University Dr. Stephen J. Lippard, Massachusetts Institute of Technology Stephen J. Lippard is the Arthur Amos Noyes Professor of Chemistry at the Massachusetts Institute of Technology where he was Head of the Chemistry Department from 1995-2005. He was born in Pittsburgh and studied at Haverford College (B. A. in Chemistry) and the Massachusetts Institute of Technology (Ph.D. in Inorganic Chemistry). After a postdoctoral year at MIT during 1965-66, he joined the faculty of Columbia University where he served until moving to MIT in 1983. Lippard’s research activities span the fields of inorganic chemistry, biological chemistry and neurochemistry. Featured are mechanistic studies of platinum anticancer drugs, the synthesis of third row transition metal cancer drug candidates, and inorganic neurotransmitters, especially nitric oxide and zinc. He has published over 850 papers on these and other topics and has co-authored a popular textbook with Jeremy Berg entitled “Principles of Bioinorganic Chemistry.” He has supervised the Ph.D. thesis research of 113 graduate students and more than that number of postdoctoral associates, many of whom hold significant positions in academic, industrial, or government institutions or in the medical or legal professions. His honors include election to the National Academy of Sciences, the Institute of Medicine and the American Academy of Arts and Sciences. Lippard was awarded the 2004 National Medal of Science by President George W. Bush, the Linus Pauling Medal in 2009 and, in 2014, the Priestley Medal, the highest award of the American Chemical Society. For more information, email [email protected] or call 412.396.4900..